Unitree’s IPO Sets The First Real Number On Humanoid Robots
The humanoid robot industry has spent three years trading on press releases, founder promises, and private funding rounds. On August 10, 2026, it will get its first daily market price. Chinese robot maker Unitree Robotics opens subscription on Shanghai’s STAR Market that day at a base valuation of roughly 42 billion yuan, about $5.9 billion at recent exchange rates, with a targeted raise of approximately $618 million, according to a July 30 Forbes analysis by Jon Markman.
Unitree is not the largest humanoid robot company by private valuation. That distinction belongs to Figure AI, which was marked at $39 billion in a recent private round despite having no commercial revenue. Unitree, by contrast, generated $235 million in 2025 revenue with 60 percent gross margins, according to its prospectus materials. It is the world’s leading humanoid robot shipper by units sold, and it is profitable, a rare combination in a category that has otherwise been funded almost entirely by private capital chasing an unverifiable future.
Why The Listing Matters Beyond Unitree
A public humanoid robot valuation changes the conversation for every other player in the sector. Until now, prospective investors in Tesla’s Optimus, Figure AI, Apptronik, 1X, Agility Robotics, Sanctuary AI, and the rest of the field have had no daily-priced benchmark to anchor their expectations. Private marks are negotiated. Public markets vote every minute. From Unitree’s first day of trading, every other humanoid valuation gets measured against a company that sells robots at a profit.
That measurement works both ways. If Unitree’s stock holds or climbs above its offering range, the rest of the sector’s private marks look conservative. If it falls, the gap between public-market discipline and private-market exuberance becomes visible. Either outcome produces a reference number that did not exist before. The same dynamic played out in the EV sector after Tesla went public in 2010, and in the broader cloud market after Amazon Web Services began disclosing revenue in 2015. Public benchmarks do not just record prices; they discipline the broader narrative.
The Tesla Comparison Investors Will Make
The most-watched comparison will be with Tesla’s Optimus program. Tesla has been the loudest voice in the humanoid category, and its market capitalization embeds significant assumed value from a robot program that has not yet shipped a customer unit. Unitree’s prospectus now offers investors a way to price the comparable: a real revenue base, real gross margins, and a real valuation multiple.
Tesla is installing first-generation Optimus production lines at its Fremont factory, with output expected later in 2026. The first units, however, are earmarked for training-data collection rather than customer deliveries. Elon Musk has called Optimus the hardest product to scale manufacturing that Tesla has ever made, because everything on the robot is new. That is the same climb Unitree spent nine years making with progressively cheaper machines.
Nvidia’s Position Across Every Outcome
One name benefits regardless of which robot maker wins the assembly race: Nvidia. Unitree’s machines run on Nvidia’s robot chips and train in Nvidia’s simulators, a dependence that has only deepened as the unit volumes have grown. The same architecture is the foundation for Tesla’s Optimus training, Figure’s Helix model, and most of the Western humanoid programs. Nvidia collects on every outcome of the Unitree listing, directly through chip sales to Unitree, and indirectly through the broader sector that the listing validates.
That positioning is why the Unitree IPO matters for the chip industry as well as for robotics. Every other chip maker working on robotics accelerators, including Qualcomm, AMD, Intel, and the long tail of Chinese AI accelerator startups, will be benchmarked against the Nvidia reference price that Unitree’s prospectus implicitly confirms. The robot-chip segment is small relative to data-center accelerators today, but the growth trajectory is steeper. Unitree’s prospectus will pull that segment into clearer focus for the first time.
What The Multiple Will Reveal
The IPO pop will get the headlines. The multiple that survives the first month of trading is the number that matters. A multiple of 25 times revenue, which is roughly what a profitable hardware business at this growth rate could command, would put Unitree’s market capitalization in the high single-digit billions of dollars. A multiple closer to 100 times revenue would mark the public market as embracing the optimistic narrative already embedded in private humanoid valuations. Anything below 10 times revenue would force a reset across the sector.
From its first day of trading, Unitree will provide the only honest benchmark the industry has. The question is whether the rest of the market is ready to take the measurement.
What It Means For The Western Field
For the Western humanoid programs, the Unitree listing introduces a different kind of pressure: valuation discipline. Private rounds at $30 billion to $40 billion for companies without commercial revenue are difficult to defend when a profitable competitor trades publicly at a fraction of that multiple. Some Western programs may accelerate revenue efforts, bringing pilot deployments forward to justify their marks. Others may accept a markdown in their next round. Either way, the public-market anchor will affect every term sheet written in the humanoid category for the next several quarters.